Detection of Pulmonary Embolism With CECT

• Status: Completed
• Trial end date: 2006-11-01
• Target enrollment: 0
• Participant gender: All

Summary

To compare the vascular enhancement of the two contrast agents in pulmonary Multi-detector CTA

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bracco Diagnostics, Inc

Criteria

Inclusion Criteria:

• Patients 18 yrs or older

• With suspected PE

• Referred for MDCTA of pulmonary arteries

• Signed informed consent

Exclusion Criteria:

• Pregnant and lactating females

• History of hypersensitivity to iodinated contrast agents

• Hyperthyroidism or pheochromocytoma

• Severe CHF

• Renal impairment

• Weight greater than 300 lbs

• Pacemaker

• Swan Ganz catheter

• Defibrillator or other intrathoracic metallic vascular device

• Received an investigational compound within 30 days of being in the study